247 related articles for article (PubMed ID: 18708022)
1. Inflammatory bowel disease following solid organ transplantation.
Hampton DD; Poleski MH; Onken JE
Clin Immunol; 2008 Sep; 128(3):287-93. PubMed ID: 18708022
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.
Verdonk RC; Haagsma EB; Van Den Berg AP; Karrenbeld A; Slooff MJ; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2006 Feb; 41(2):205-11. PubMed ID: 16484126
[TBL] [Abstract][Full Text] [Related]
3. Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.
Wörns MA; Lohse AW; Neurath MF; Croxford A; Otto G; Kreft A; Galle PR; Kanzler S
Am J Gastroenterol; 2006 Aug; 101(8):1931-7. PubMed ID: 16790037
[TBL] [Abstract][Full Text] [Related]
4. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.
Riley TR; Schoen RE; Lee RG; Rakela J
Am J Gastroenterol; 1997 Feb; 92(2):279-82. PubMed ID: 9040206
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary associations with inflammatory bowel disease.
Knight C; Murray KF
Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):681-91. PubMed ID: 19929587
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.
Sandhu A; Alameel T; Dale CH; Levstik M; Chande N
Aliment Pharmacol Ther; 2012 Jul; 36(2):159-65. PubMed ID: 22616981
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune liver diseases in children - what is different from adulthood?
Mieli-Vergani G; Vergani D
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):783-95. PubMed ID: 22117642
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.
Verdonk RC; Dijkstra G; Haagsma EB; Shostrom VK; Van den Berg AP; Kleibeuker JH; Langnas AN; Sudan DL
Am J Transplant; 2006 Jun; 6(6):1422-9. PubMed ID: 16686766
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer after orthotopic liver transplantation.
Silva MA; Jambulingam PS; Mirza DF
Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease.
Tripathi D; Neuberger J
Semin Liver Dis; 2009 Aug; 29(3):286-96. PubMed ID: 19676001
[TBL] [Abstract][Full Text] [Related]
12. Diarrhea in liver transplant recipients: etiology and management.
Ginsburg PM; Thuluvath PJ
Liver Transpl; 2005 Aug; 11(8):881-90. PubMed ID: 16035068
[TBL] [Abstract][Full Text] [Related]
13. Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
Kochhar G; Singh T; Dust H; Lopez R; McCullough AJ; Liu X; Fung J; Shen B
Inflamm Bowel Dis; 2016 Jul; 22(7):1670-8. PubMed ID: 27306073
[TBL] [Abstract][Full Text] [Related]
14. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
[TBL] [Abstract][Full Text] [Related]
16. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
Villamil A; De Paula JA; Galdame O; Piccioni H; Ciardullo M; De Santibañes E; Gadano A
Acta Gastroenterol Latinoam; 2008 Dec; 38(4):252-9. PubMed ID: 19157380
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Singh S; Loftus EV; Talwalkar JA
Am J Gastroenterol; 2013 Sep; 108(9):1417-25. PubMed ID: 23896954
[TBL] [Abstract][Full Text] [Related]
18. The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
Kwon JH; Farrell RJ
Crit Rev Oncol Hematol; 2005 Oct; 56(1):169-78. PubMed ID: 15979323
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal.
Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Steinberg T; Kaplan M; Wright F; Kam I
Liver Transpl; 2008 Sep; 14(9):1281-6. PubMed ID: 18756454
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of inflammatory bowel disease in the organ recipient.
Indriolo A; Ravelli P
World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
